Margin Recovery Momentum Meets Growth Headwinds — What Q2 Must Show
Birlasoft sets up Q2 FY27 results on record high margins but slowing organic revenue growth. Street expects 15–20% PAT expansion on operational leverage. The real question: can deal momentum convert to Q2 revenue acceleration, or will 4–7% growth persist?
The Setup: Margin Recovery Narrative vs Growth Stall
Birlasoft heads into Q2 FY27 riding strong margin recovery (Q1 EBITDA held steady, PAT surged 51% YoY on operating leverage + tax benefits). But the print masks a growth challenge: revenue expanded only 2.3% sequentially and 7.4% YoY — well below the 15–18% expansion IT services peers are delivering. The Street has trimmed revenue growth estimates for FY27 to 4.7% (down from 5.06%), even as PAT growth expectations remain at 22.7%. For Q2, the real test is whether deal TCV momentum (up 19.9% YoY) translates into revenue uplift, or if the macro headwind persists.
What to Expect
~₹1,405 Cr
flat-to-+1.5% QoQ from Q1's ₹1,379.4 Cr; 4–6% YoY on conservative guidance
~₹155–170 Cr
15–20% YoY growth expected on operational leverage; margin hold at ~12%
~13–14%
management targets sustainable >15%; Q2 likely hold steady from Q1 levels
Build guidance TBD
Q1 $169M (up 19.9% YoY, -18.8% QoQ). Watch commentary on deal wins & pipeline
A strong Q2 means: revenue tracking ₹1,410–1,430 Cr (+2.3–3.7% QoQ), PAT at ₹165–175 Cr (18–22% YoY), margin sustenance, and clarity on FY27 deal conversion. Management commentary confirming deal TCV is flowing into signings and guiding H1 momentum into H2 would de-risk the growth concern. A weak Q2 looks like: flat-to-negative sequential revenue, PAT growth offset by margin compression, deal TCV commentary signalling slowing pipeline, or guidance cut to FY27 revenue growth below 4%. This would trigger a re-rating miss — the Street's ₹357 target assumes the 4.7% growth materializes and margin sits at 13–14%.
On Track for FY27 Guidance?
Management reiterated in Q1 that H1 FY27 deal signings will improve YoY and FY27 signings will exceed FY26 levels. They've also committed to a sustainable EBITDA margin aspiration of >15%, though Q2 will likely hold near current 13–14% (recovery from lows, but not yet target). Q1 set a strong profit baseline; Q2 must confirm it's sustainable, not a one-off tax-driven spike. The big watch is whether organic revenue growth can inflect from 7.4% YoY back to management's implied 8–10% range — right now, consensus is braced for 4–7%.
What the Street Says
Since Last Quarter: Three Signals
1 · OpenAI Select Partner (Oct 8)
Birlasoft named OpenAI Select Partner — a narrative boost for AI-led transformation. Signals intent to compete in enterprise AI solutions, a high-margin segment. Street sees this as a positioning move for deal diversification away from pure modernization work.
2 · CSO Resignation (Sep 11)
Chief Strategy Officer Ankur Vaish departed to pursue other opportunities, effective Sep 19. No replacement announced yet. Routine for a CSO move; watch for any guidance change or strategic pivot commentary on Oct 28.
3 · Interim Dividend Signal (Oct 20)
Board announced interim dividend with record date Nov 5 (to be declared on Oct 28 result day). Signals capital confidence and cash generation — positive for shareholder returns, though magnitude TBD.
Three Things to Watch on Oct 28
1 · Revenue Sequential Growth & FY27 Outlook
Does Q2 revenue land at ₹1,410 Cr+ (justifying ₹1,420+ Cr H1 run-rate)? Is management maintaining the 4.7% FY27 growth guide, or adjusting up/down? Sequential growth below 1% signals macro persists; +2%+ QoQ would ease growth anxiety and support the ₹357 target.
2 · Margin Trajectory & >15% EBITDA Aspiration Timing
Does EBITDA margin hold at 13–14%, or compress? When does management expect to reach the stated >15% target? Q2 at 12%– signals margin headwind; hold or improve signals operating leverage working and supports PAT growth narrative.
3 · Deal Pipeline & TCV Guidance Clarity
Management commentary on deal signings (pipeline health, sector mix, duration of deal ramp). If Q2 TCV grows QoQ and management guides H2 deal conversion momentum, the growth re-acceleration narrative gains traction. Flat/down TCV would validate bear case on macro headwinds and deal quality.
Birlasoft's Q2 FY27 print is a margin-plus-growth equilibrium test. The Street expects steady PAT expansion and margin hold; management's challenge is proving organic revenue growth is inflecting, not stalling. Consensus has already trimmed FY27 growth to 4.7%, so a print that confirms guidance is 'in-plan' (no surprise downside). A beat comes from Q2 revenue at ₹1,420 Cr+, margin hold/expansion, and deal commentary that supports an 8–10% FY27 growth path — that's what unlocks the ₹357 target. If Q2 shows further sequential slowdown and deal TCV weakness, expect the bear case (₹300–₹320) to dominate — valuation reset on lower growth and re-rating delay.
Birlasoft Q2 FY27 consolidated: tax relief lifts PAT 37.5% YoY, margin cools
PAT +37.5% YoY · revenue +6.57% · margins compressing
₹1,416.2 Cr
+6.57% YoY
₹159.65 Cr
+37.5% YoY
10.94%
+2.3pp YoY
₹5.67
Birlasoft's consolidated revenue for the quarter ended September 30, 2026 was ₹1,416.2 Cr, up 6.6% YoY and 2.7% QoQ, with consolidated PAT of ₹159.6 Cr (basic EPS ₹5.67) — up 37.5% YoY but down 0.8% sequentially from Q1 FY27's ₹161.0 Cr. The YoY profit jump overstates operating performance: EBITDA margin (OPM) compressed to 15.2% from 16.05% a year ago and 16.15% last quarter, so pre-tax profit grew a far more modest 7.1% YoY to ₹225.0 Cr, roughly in line with revenue. The bulk of the PAT growth instead comes from the effective tax rate normalizing to 29.05%, down sharply from an unusually high 44.7% in the year-ago quarter — a tax-base effect, not an operating one.
Q2 FY-2027 vs prior quarters
Both guided checkpoints from management's August concall played out as flagged: the 170–200bps EBITDA dilution from the July wage hike showed up as a roughly 90–100bps sequential margin decline, landing just inside the "15%+" floor management had set, and FY27 ETR of 29.05% sits squarely in the guided 29–30% band. Management gave no formal revenue guidance this quarter citing market volatility, so topline growth cannot be graded against a target, and no reliable Street consensus for this specific quarter's print could be confirmed via search, so vsStreet is treated as unknown rather than assumed.
The stock went into the print at ₹306.1, up 11.7% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
NPM expanded to 11.3% YoY (from 8.6%) on the lower tax rate but eased from 11.4% in Q1 FY27
EBITDA margins to trend at 15%+ with Q2 dilution from 170–200 bps wage hike (July effective). H1 deal signings will materially exceed prior year H1. ETR expected 29–30% for FY27. No formal revenue guidance citing market volatility.
— This quarter: met
Segment growth was uneven: Manufacturing (+13.0% YoY to ₹548.6 Cr) and BFSI (+10.4% YoY to ₹364.0 Cr) drove the topline, while Energy & Utilities (-1.5% YoY to ₹226.0 Cr) and Life Sciences & Services (-2.3% YoY to ₹277.7 Cr) both contracted. Standalone (India entity) revenue of ₹858.4 Cr grew 24.4% YoY versus consolidated's 6.6%, lifting standalone's share of consolidated revenue to 60.6% from 51.9% a year ago — a divergence large enough that readers comparing the two bases will see materially different growth stories this quarter; it likely reflects how work is billed across entities rather than a swing in underlying demand, though the filing doesn't explain it directly. The quarter also saw Birlasoft named an OpenAI Select Partner (October 8) and CSO Ankur Vaish's resignation effective September 19 — neither shows up as a line-item impact this quarter. The Board declared an interim dividend of ₹3/share (150% of face value), record date November 5, 2026.
W1
Whether EBITDA margin holds near 15.2% or recovers toward management's "15%+" guided range as the July wage-hike dilution fully annualizes
W2
H1 deal-signings/TCV trend versus management's claim it would "materially exceed" prior-year H1 — not disclosed in this filing, needs confirmation from the investor update/concall
W3
Whether the Energy & Utilities and Life Sciences & Services verticals (down 1.5% and 2.3% YoY respectively) stabilize or continue to drag on growth next quarter
Margin defended, order book soft—AI positioning unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met margin 15.2% vs 15%+ and ETR 29% vs 29-30%; missed deal signings narrative (15% not 'material'); order book acknowledged as soft.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
EBITDA margin defended at 15.2% despite wage headwinds, and YoY PAT growth solid at +37.5%. However, order book miss and QoQ PAT decline (-0.8%) flag execution risk. AI positioning (AWS, OpenAI) structurally sound but unproven on revenue impact. Management must prove H2 deal conversions to sustain confidence.
₹1416.2 Cr
Revenue · +6.6% YoY₹159.6 Cr
Reported PAT · +37.5% YoYFlat
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew 2.1% QoQ in constant currency, 2.7% rupee terms
METReported 2.1% CC, 2.7% INR sequential growth confirmed
EBITDA margin within 15%+ range despite wage dilution 170-200 bps
METDelivered 15.2% margin, in line with guidance range
H1 deal signings will materially exceed prior year H1
OVERSTATED$285M H1, +15% YoY; management admits order book miss, expected better delivery
ETR expected 29-30% for FY27
METQ2 ETR 29%, on track with guidance
Quality of revenue is really going up
METManagement cites tail-account exit and mix improvement, but order book miss signals execution gap
Earnings quality
What changed since the last call
AI positioning upgraded
UpgradeAWS AI Services Competency achieved; OpenAI select partner secured. Agentic AI code generation ~25% up from ~10% few months prior; 10% improvement in quarter
Order book narrative downgraded
DowngradeManagement expected stronger order book in Q2. Admitted 'we did not do a good job.' Deals pushed to Q3/Q4 vs prior expectation.
E&U flagged as one-time decline
NeutralE&U soft due to one European client ramp down. Management claims structural recovery in 2-3 quarters, not permanent degradation.
Margin guidance reconfirmed despite costs
MaintainedWage hike 170-200 bps delivered, offset by operational efficiencies and revenue quality mix. EBITDA 15.2% vs 15%+ guidance.
Sales and capability investment intensified
UpgradeLeadership hires completed; sales force expansion ongoing; dedicated AI-first capability building across service lines
The Q&A
Analysts pressed hard on order book depth, deal win vs. deal loss, and whether growth is defensible given top-20 client concentration at 70% and E&U decline. Management defended on margin stability, revenue quality, and AI upside, but offered limited hard near-term deal conversion commitments. Tone defensive on execution but optimistic on structural AI tailwinds.
Order book quality — Sandeep Shah, Equirus Securities
PartialExit from non-profitable accounts completed. Annuity growing up. Confidence H2 better than H1 on signings and order book.
EBITDA margin trajectory — Dipesh Mehta, Emkay Global
AnsweredWage increment 170 bps impact Q2. Operating efficiencies and revenue quality gains offset. Expect ~15% margin level sustained. Deal intake: disappointed but expected better; pushing into Q3/Q4.
Advanced AI services margins — Girish Pai, BOB Capital Markets
PartialAdvanced AI driving margin via Agentic AI (code generation up 10% this quarter). Offshore intensity increasing. Competitive pressure acknowledged; margin confidence from capability depth.
Book-to-bill and deal sizing — Ravi Menon, Axis Capital
PartialBook-to-bill much better; trailing TCV up 9% YoY. Deal sizes becoming larger. Not yet at level needed for future growth trajectory.
Demand environment stability — Shraddha Agrawal, Asian Markets Securities
AnsweredDemand environment unchanged. Challenges remain. Utilization steady with incremental gains. Focus on revenue quality over headcount.
Top client concentration; E&U recovery — Vikas Ahuja, Antique Stock Broking
PartialTop 10, 20 all growing in line with company. E&U ramp down is one-time client issue; structural recovery 2-3 quarters. Confidence on account health.
Offshore intensity in advanced AI — Amit Chandra, HDFC Securities
AnsweredAdvanced AI work increasingly offshore. Top 5/10/20 all growing. Manufacturing on recovery; very confident directional growth.
AI deployment scope — Sujit, Individual Investor
AnsweredBoth. Internal: ~25% code via Agentic AI. External: AI-infused across all service lines; platforms (Cogito, Lynx, Sigma) driving differentiation.
Sales hiring and deal flow timing — Anmol Garg, DAM Capital
PartialLeadership hiring done. Need couple quarters for leaders to be productive. Pipeline stronger; AI conversations increasing. No hard Q3 impact expected.
H2 outlook and macro resilience — Sudheer, Kotak Asset Management
PartialQ4 expected strongest (seasonal renewals, deal conversions). Beyond H2 depends on H2 signings. Management focused on order book execution; no breakout guidance.
Balance sheet capex — Girish Pai, BOB Capital Markets (repeat)
AnsweredPPE up from tech infra refresh (data centers, tech infrastructure). Intangibles from capability investments. No formal capex guidance.
Guidance
No formal revenue guidance; relying on deal execution and order book conversion
MediumManagement emphasized order book quality over growth targets. H2 expected better than H1 based on ongoing conversations.
EBITDA margins sustain ~15% level (15%+ range)
HighWage hike 170-200 bps offset by operational efficiencies, revenue quality mix, and Agentic AI productivity. Q2 delivered 15.2%.
Ongoing capex in tech infrastructure and capability building; no formal target provided
MediumReinvesting in data centers, tech infra refresh, service line capabilities. Part of capability and sales investment strategy.
Risks the call surfaced
Order book execution
HighManagement admits 'we did not do a good job' on order book. Q2 deals pushed to Q3/Q4. If H2 signings falter, growth trajectory stalls.
Customer concentration
MediumTop 20 clients = 70% of revenue. One European Energy & Utilities client ramp down caused segment softness. High concentration is structural risk.
Seasonal Q3 headwind
MediumQ3 historically soft due to summer furloughs, holidays, lower client activity. Management expects Q3 soft; did not rule out surprises.
Competitive AI pricing pressure
MediumLarge integrators competing on advanced AI services. Management acknowledged pricing pressure in competitive deals. Risk to margin expansion despite capability advantage.
E&U recovery timing
MediumManagement expects recovery in 2-3 quarters (Q4/Q1) but timeline is estimate. If client ramp remains longer, E&U drag persists.
Management
Score 6/10. Honest on shortcomings; Angan Guha explicitly acknowledged order book miss. Chandru provided detailed margin walk-through. Mostly transparent but some evasion on client-specific details and E&U timeline certainty. Mixed. Met EBITDA margin 15.2% vs 15%+ and ETR 29% vs 29-30%. Missed deal signings narrative (15% vs 'materially exceed') and order book volume. Revenue growth modest 6.6% YoY.
1 · Q4 FY27
Deal conversions expected; seasonal pickup in renewals. Management confident Q4 will be strong quarter.
2 · H2 FY27 onwards
Manufacturing segment inflection; +5.2% QoQ already showing momentum; discrete and process manufacturing wins materializing
3 · Q4 FY27–Q1 FY28
E&U segment recovery expected. Management timeline: 2-3 quarters from Q2 for European client ramp-down recovery.
Management must prove H2 deal conversions to sustain confidence.
Margin Held, Momentum Soft—the Order Book Miss That Changes the Narrative
Birlasoft defended EBITDA margins at 15.2% despite a ₹170–200 crore wage hike, and PAT grew 37.5% year-on-year. But sequential profit fell 0.8%, deal signings came in 15% (not 'materially exceed'), and the CEO admitted 'we did not do a good job' on the order book. The tension: how much of this quarter is margin resilience, and how much is a stalled pipeline masking the next decline?
₹159.6 Cr
+37.5% YoY
-0.8% QoQ
Despite +2.7% revenue
15.2%
vs 15%+ guidance (held)
$285M
+15% YoY (narrative: 'materially exceed')
On the headline, Birlasoft looks robust: profit surged 37.5% year-on-year, margins held at 15.2% despite wage headwinds, and the company collected cash faster than ever (DSO 51 days, a two-year best). But the real quarter is in the gap between what management claimed coming in and what it admits now. Sequential profit fell even as revenue grew. Deal signings rose 15%, not the 'material' excess promised. And on the call, CEO Angan Guha acknowledged: 'on the order book, I think we did not do a good job.' That admission—not the margin beat—is the quarter's core fact.
The margin call: wage hike offset by mix and productivity
Birlasoft took a ₹170–200 crore hit from salary increases effective July but held EBITDA at 15.2%, right in the guided 15%+ band. How? Revenue quality improved (the company exited unprofitable tail accounts). Manufacturing surged 5.2% QoQ—the strongest vertical. Agentic AI code generation nearly doubled to ~25% of the codebase from ~10% a few months prior, lifting internal productivity. Collections tightened. This is textbook operational excellence, and it delivered the number. But that excellence came at the cost of capacity: Birlasoft is running faster to stay in place.
EBITDA margins sustain ~15% despite wage hike
Delivered 15.2%; offset by revenue quality mix and Agentic AI productivity gains
Supported
H1 deal signings will materially exceed prior year
H1 $285M, +15% YoY; management admits order book miss and deals pushed to Q3/Q4
Overstated
ETR expected 29–30% for FY27
Q2 ETR 29%; tracking to guidance
Supported
Revenue quality really going up
Tail-account exit confirmed; top 20 clients all growing in line with company
Supported (but Q2 sequential PAT -0.8% flags execution gap)
What changed on this call
AI positioning upgraded: AWS AI Services Competency achieved; OpenAI select partner secured. Agentic AI code generation ~25% vs ~10% prior.
Order book narrative downgraded: CEO admitted 'we did not do a good job.' Deals pushed to Q3/Q4 vs prior expectation for Q2 strength.
Manufacturing flagged as recovery driver: +5.2% QoQ with discrete and process manufacturing wins; management cites confidence for H2.
E&U one-time, not structural: One European client ramp down caused softness. Recovery expected 2–3 quarters (Q4 onwards). Not a permanent degradation.
Sales and capability investment intensified: Leadership hires completed; sales expansion ongoing; AI-first approach embedded across verticals.
The bull-bear ledger
Margin defended at 15.2% despite 170–200 bps wage dilution
YoY PAT +37.5% shows strong operational leverage
AWS Competency + OpenAI partner status provide structural differentiation in AI services
Manufacturing recovery +5.2% QoQ; discrete/process wins materializing
Cash collections excellent; DSO 51 days (2-year best); balance sheet $300.4M strong
QoQ PAT -0.8% despite +2.7% revenue; signals compression and investment drag
Order book miss acknowledged; deals pushed to later quarters
Deal signings +15% YoY does not qualify as 'materially exceed' narrative
Top 20 clients = 70% of revenue; one European account caused E&U soft
AI monetization unproven; AWS and OpenAI partnerships strategic but no binding revenue mechanism
Q3 seasonal soft from furloughs; H2 recovery hinges on execution
E&U recovery timeline 2–3 quarters is management estimate, not guaranteed
Risks, ranked by how much they should concern a holder
Order book execution; deal conversions stall in H2
HighIf H2 deal signings miss or conversions push into FY28, revenue growth stalls and the margin-led story breaks. Management must prove H2 execution; the order book miss is recent and material. This is the #1 watch.
Customer concentration; one-account dependency
MediumTop 20 = 70% of revenue. One European Energy & Utilities client ramp down softened a whole segment. No single-client loss should move the needle this much; it signals lack of diversification. Net new logo growth is critical to reduce concentration.
Seasonal Q3 headwind from furloughs; momentum loss
MediumQ3 historically soft due to summer furloughs and vacations. Management flagged it. If furloughs exceed expectations or client activity stays muted, the Q4 recovery assumption (which is priced into the narrative) fails.
AI competitive pricing pressure; margin expansion at risk
MediumLarge systems integrators competing aggressively on advanced AI services. Management acknowledged pricing pressure in competitive deals. Despite AWS/OpenAI differentiation, margin expansion in AI services is not assured. Capability investments may not offset pricing pressure.
E&U recovery timeline slips; segment remains soft
MediumManagement expects recovery in 2–3 quarters (Q4/Q1 FY28). That is an estimate, not a guarantee. If the European client ramp down extends longer or other accounts face similar headwinds, E&U stays a drag.
How the street is positioned
Price action and valuation: Stock stands at ₹322.2, neutral trend, above the 20-day and 50-day averages (₹304.69 and ₹292.44) but below the 200-day (₹335.56). RSI 57.8 is neutral—neither overbought nor oversold. The 52-week range is ₹267.1–₹474; the stock is +20.63% off the low but down 62.62% from its all-time high of ₹861.85. The drawdown from ATH is steep, but the recovery from the 52-week low is material. Volume trend is INCREASING, which could signal accumulation at these levels or continued indecision.
Institutional flows: FII ownership fell 0.87 percentage points QoQ (from 13.65% to 12.78%), and DII ownership dropped 1.36pp (from 23.35% to 21.99%). Promoter holding unchanged at ~40.4%. The FII selling is modest but real—institutions trimmed into the quarter, not added. DII also reduced exposure slightly. Neither is a panic, but both suggest cautious sentiment at current levels.
Bulk/block activity: Over the past six months, the tape shows small-size buying (QE Securities LLP, Alphagrep, Societe Generale) and selling, with no promoter or insider-linked activity flagged. The trades are in the ₹339–₹342 range—slightly above current price—suggesting some profit-taking from earlier buyers but no distress. No red flags on insider selling near highs.
Street verdict: The market is pricing a hold. The recovery from the 52-week low is real, but FII and DII flows are flat to negative. The stock is not exciting institutional buyers at current levels, and the order book miss is visible on the tape. Margin defense is priced in; the debate is whether H2 deal execution will follow.
The debate
What to watch next
1 · Q3 deal pipeline and conversion velocity
Management expects Q3 to be soft (furloughs) but H2 overall stronger. Watch the Q3 deal intake and whether it actually flows into Q4. If Q3 deals miss, the H2 narrative collapses. The Q4 'strong quarter' assumption needs Q3 to lay the groundwork.
2 · H2 order book execution and new deal signings
Management must convert $X in H2 deals to justify the guidance reset. Aim: signings material above H1 $285M to prove execution capability. This is the linchpin. If H2 $300M+ in signings materializes, the order book narrative flips to recovery. If H2 signings stall at H1 levels, the miss compounds.
3 · AI revenue contribution and margin trajectory
AWS Competency and OpenAI partnerships must translate to new logos and margin expansion. Watch for AWS-enabled deal wins, Agentic AI services TCV, and whether Cogito/Lynx/Sigma platforms drive differentiation. If advanced AI margins expand and contribute meaningfully to growth, the structural bull thesis validates. If AI remains a cost center, the growth upside is capped.
The number to track from here
EBITDA margin at 15%+ is held. But the real north star is H2 deal conversion rate and H2 order book output. If H2 order book exceeds H1 $285M by 10%+ and conversion velocity accelerates in Q4, the bear thesis weakens and the stock re-rates. If H2 signings stay flat to H1, sequential compression will worsen into Q3 and beyond. The margin is defended. The growth is not.
Birlasoft is a steady franchise with structural tailwinds (AI adoption, manufacturing recovery) and strong operational discipline (margin defense, collections). But it is facing a near-term execution hurdle: the order book miss is real, customer concentration is a drag, and deal conversions must prove out in H2. Sequential PAT compression despite revenue growth is the warning flag. This is not a step-change quarter; it is a consolidation. Margin held, but momentum soft. The next quarter determines whether margin excellence can anchor a growth recovery or whether Birlasoft has entered a slower-growth cycle despite AI investments.
Verdict: Hold. Rating resets on H2 deal execution and AI monetization proof points.